Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic polymorphisms in assessing interindividual variability in delivered dose.

L T Haber1, A Maier, P R Gentry

  • 1Toxicology Excellence for Risk Assessment, 1757 Chase Avenue, Cincinnati, OH 45223, USA. haber@tera.org

Regulatory Toxicology and Pharmacology : RTP
|June 8, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Consideration of Carcinogenicity and Mode of Action Information by an Independent Expert Panel to Support Derivation of No-Significant-Risk-Level Values for Vinyl Acetate Monomer.

Regulatory toxicology and pharmacology : RTP·2026
Same author

Quantitative methods for the risk assessment of drinking water contact chemicals following the NSF/ANSI/CAN 600 Standard - Part II: advanced methods.

Toxicology mechanisms and methods·2026
Same author

Application of artificial intelligence on magnetocardiology.

Clinical hemorheology and microcirculation·2026
Same author

GRASPion: An open-source, programmable brainbot for active matter research.

The Review of scientific instruments·2026
Same author

Multimodality assessment of aortic valve area in aortic stenosis: a multicenter validation study.

The international journal of cardiovascular imaging·2025
Same author

Dermal wipe sampling method development and validation for semivolatile and nonvolatile flame-retardant compounds TBBPA and TPP for use in occupational exposure assessments.

Journal of occupational and environmental hygiene·2025
Same journal

The NTP Chronic Inhalation Study Does Not Support an Inherent Lung Cancer Hazard of Talc: Implications of Lung Particle Overload and Maximum Tolerated Dose.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

Which carcinogenicity study should I use? Automated identification of reliable studies.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

Adoption of artificial intelligence in drug review across the lifecycle: Transformation of regulatory decision-making.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

Cardiovascular outcomes following intrauterine and lactational exposure to cyantraniliprole in male Wistar rats.

Regulatory toxicology and pharmacology : RTP·2026
Same journal

Pesticide residue and mycotoxin occurrence in apples and their impact on human health in Morocco.

Regulatory toxicology and pharmacology : RTP·2026
See all related articles

Genetic polymorphisms significantly contribute to human variability in toxicant susceptibility. Integrating genetic data with physiologically based pharmacokinetic (PBPK) modeling helps quantify this population variability.

Area of Science:

  • Environmental Health Sciences
  • Toxicology
  • Genetics

Background:

  • Human susceptibility to toxicants varies significantly.
  • Genetic polymorphisms are increasingly recognized as a key factor in this variability.
  • Physiologically based pharmacokinetic (PBPK) modeling is evolving to incorporate genetic data.

Purpose of the Study:

  • To analyze the contribution of genetic polymorphisms in metabolic enzymes to human variability in toxicant susceptibility.
  • To identify uncertainties and necessary assumptions for integrating polymorphism data into PBPK models.
  • To assess the role of genetic factors in variability for methylene chloride, warfarin, parathion, and dichloroacetic acid.

Main Methods:

  • Case study analysis of four diverse compounds.

Related Experiment Videos

  • Integration of genetic polymorphism data with PBPK modeling.
  • Identification of key uncertainties in applying polymorphism data.

    • Main Results:

    • Several uncertainties hinder precise quantification of variability from polymorphisms.
    • Key challenges include enzyme system interactions, coexposure effects, allelic frequencies, kinetic data gaps, low-frequency alleles, and in vitro/in vivo discrepancies.
    • The study highlights the need for further data acquisition and refined PBPK modeling approaches.

    Conclusions:

    • Genetic polymorphisms are a substantive source of human variability in toxicant susceptibility.
    • Further research and data are critical for robust integration of polymorphism data with PBPK modeling.
    • This approach can improve the quantitative assessment of population variability in risk assessment.